91 related articles for article (PubMed ID: 29355489)
1. iTRAQ analysis of urinary proteins: Potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma.
Jayapalan JJ; Lee CS; Lee CC; Ng KL; Junit SM; Hashim OH
Clin Biochem; 2018 Mar; 53():127-131. PubMed ID: 29355489
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
[TBL] [Abstract][Full Text] [Related]
3. Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma.
Zhou Z; Zhang J; Jiang F; Xie Y; Zhang X; Jiang L
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28684549
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter.
Yao Z; Yin P; Su D; Peng Z; Zhou L; Ma L; Guo W; Ma L; Xu G; Shi J; Jiao B
Mol Biosyst; 2011 Sep; 7(9):2608-14. PubMed ID: 21713270
[TBL] [Abstract][Full Text] [Related]
5. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
[TBL] [Abstract][Full Text] [Related]
6. Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.
Choi MH; Moon JY; Cho SH; Chung BC; Lee EJ
BMC Cancer; 2011 Aug; 11():342. PubMed ID: 21824401
[TBL] [Abstract][Full Text] [Related]
7. Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins.
Abdullah MI; Lee CC; Mat Junit S; Ng KL; Hashim OH
PeerJ; 2016; 4():e2450. PubMed ID: 27672505
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
9. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
11. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
[TBL] [Abstract][Full Text] [Related]
12. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation.
Chernaya G; Mikhno N; Khabalova T; Svyatchenko S; Mostovich L; Shevchenko S; Gulyaeva L
Surg Oncol; 2018 Dec; 27(4):702-708. PubMed ID: 30449496
[TBL] [Abstract][Full Text] [Related]
13. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
14. Multicompartment metabolism in papillary thyroid cancer.
Curry JM; Tassone P; Cotzia P; Sprandio J; Luginbuhl A; Cognetti DM; Mollaee M; Domingo M; Pribitkin EA; Keane WM; Zhan TT; Birbe R; Tuluc M; Martinez-Outschoorn U
Laryngoscope; 2016 Oct; 126(10):2410-2418. PubMed ID: 26666958
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer].
Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A
Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
Li M; Song Q; Li H; Lou Y; Wang L
PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
[TBL] [Abstract][Full Text] [Related]
17. High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk.
Zhao H; Li H; Huang T
Biol Trace Elem Res; 2018 Aug; 184(2):317-324. PubMed ID: 29164514
[TBL] [Abstract][Full Text] [Related]
18. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
19. A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer.
Zhang L; Fang C; Liu L; Liu X; Fan S; Li J; Zhao Y; Ni S; Liu S; Wu Y
Environ Int; 2018 Nov; 120():388-393. PubMed ID: 30125856
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
